Gastroenterology
Ileus
9
Pipeline Programs↗
0
Active Trials↗
8
Companies Involved↗
Ileus is an early-stage landscape with 9 programs across 8 companies. The most active players are Kaken Pharmaceutical, Amring, Otsuka. 8 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 3
No programs
Analysis
Trial Status
3
clinical trials
Completed2 · 67%
Terminated1 · 33%
Clinical Trials
Trial Activity
The Effects of Combined Gum-chewing and Parenteral Metoclopramide on Post-operative Ileus
Completed·—·Phase 4·NCT05669781·105 enrolled
Alvimopan as Rescue in Post op Ileus
Terminated·—·Phase 3·NCT02742181·14 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)